The FDA approved the fixed-dose combination of emtricitabine and tenofovir alafenamide for PrEP, but advocates hope to see more research on the HIV prevention drug's efficacy for receptive vaginal sex for cisgender women and transgender men.
Young people in the nation's capital are living in the middle of some of the worst structural and systemic inequalities in America. We should be helping them out.
We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.
This inspiring moment from the U.S. Conference on AIDS illustrates how relationships can produce results for advocates.
Creating Social Spaces for Black Gay and Bisexual Men Increased HIV Care-Seeking Behavior, Self-Acceptance
My Brother's Keeper's "Connect With Us" intervention in Jackson, Mississippi, shows that community self-empowerment improves intention to engage in health care and use safe sex practices.
Sept. 19, 2019: HIV antiretroviral stewardship plans in hospitals can save money -- and lives; demographic correlates of PrEP interruption; HIV and atrial fibrillation risk; cytopenias common, despite viral suppression.
Communities Should Be Involved in Research. Here Are Some Key Insights on Good Participatory Practice.
Increasingly, researchers are looking for ways to involve communities not just by participating in trials, but by helping shape these projects. But, how do you go about making sure affected communities are at the table?
Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.
Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.
A chlamydia infection makes HIV acquisition more likely.